Cue Biopharma Inc (CUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 21,942 | 2,149 | 2,954 | 421 | 1,576 |
| Gross Profit | 21,942 | 2,149 | 2,954 | 421 | 1,576 |
| Operating Expenses | 19,965 | 9,744 | 11,589 | 12,720 | 11,210 |
| Operating Income | 1,977 | -7,595 | -8,635 | -12,299 | -9,634 |
| Interest Expense | 109 | 75 | 45 | 128 | 152 |
| Other Income | 217 | 222 | 198 | 170 | 290 |
| Pre-tax Income | 2,085 | -7,448 | -8,482 | -12,257 | -9,496 |
| Net Income Continuous | 1,585 | -7,448 | -8,482 | -12,257 | -9,496 |
| Net Income | $1,585 | $-7,448 | $-8,482 | $-12,257 | $-9,496 |
| EPS Basic Total Ops | 0.05 | -0.07 | -0.09 | -0.17 | -0.10 |
| EPS Basic Continuous Ops | 0.05 | -0.07 | -0.09 | -0.17 | -0.10 |
| EPS Diluted Total Ops | 0.05 | -0.07 | -0.09 | -0.17 | -0.10 |
| EPS Diluted Continuous Ops | 0.05 | -0.07 | -0.09 | -0.17 | -0.10 |
| EPS Diluted Before Non-Recurring Items | 0.01 | -0.07 | -0.09 | -0.17 | -0.13 |
| EBITDA(a) | $2,634 | $-7,687 | $-8,527 | $-12,189 | $-9,527 |